B-SPOT
CONSULTING INC
CLINICAL & BUSINESS ANALYSIS – GUIDING DEVELOPMENT STRATEGY
CLINICAL & BUSINESS ANALYSIS – GUIDING DEVELOPMENT STRATEGY
CARDIOLOGY NEUROLOGY ONCOLOGY INFLAMMATION MEDICAL DEVICES
What do you get when you combine years of clinical development and operational expertise with the skills of a financial analyst? You get someone who can develop creative AND pragmatic solutions for development challenges to advance your business strategy and programs.
I have effectively played both leading and supportive roles on different cross-functional teams to deliver on project goals.
My unique background and skill set has proven effective at creating roadmaps for value creation within small organizations: licensing deals, pinpointing commercial strategy, developing future clinical programs, and nurturing professional relationships with clinical thought leaders. Whether you are looking to develop a financial model to show future investors your path to clinical and commercial success, or a deep dive into the clinical and competitive details of your product and market, I can augment your internal team and provide the needed bandwidth for these projects.
I am an excellent communicator with the ability to translate peer-reviewed science and concepts to diverse business and clinical audiences. I’ve successfully worked with internal/external clinical/business groups to prepare grants, clinical protocols, business plans, value dossiers, and medical writing for clinicians and investors. I have a passion for working in an entrepreneurial environment and developing innovative products, just like you do, and with over 10 years of proven effectiveness in working remotely, my client list is companies both domestic and international.
Analytics – Strategy – Decision – Execution
If the roadmap to success starts with analysis, then that analysis has to be rigorous, detailed, and stress-tested. The phrases “There are bumps in every road” and “The Devil’s in the details” are well-worn sayings for a reason. By critically analysing current programs, it is possible to anticipate their future state, the problems getting there, and to avoid those potholes along the way. Analysis, Strategy, Decision, Coordination, Execution.
Each client project starts with an in-depth conference call or meeting, where we align goals and expectations. Clear communication is very important to project success and client satisfaction, and regular ‘check-ins’ by email, phone or in-person ensures that we are on the same page and heading in the right direction. Whether you are looking for the best clinical program for your product, or investigating strategic options for your company, you want to have someone on your team who can navigate between those levels to provide objective plans supported by rigorous analysis and operational experience.
I am excited to be involved in developing programs for innovative technologies with entrepreneurs, and grateful that my clients have welcomed me as a member of their team. Whatever happens on your pathway to success, I will be your partner and support you from analysis to execution. I can be a short-term resource or a long-term partner, so give me a call and let’s talk about your needs and how I might be able to help you in your path to success.
"SOME OF WHAT I DO"
my financial modelling presentation deck
SAMPLE ENGAGEMENTS
. . . the most sophisticated financial model I've ever seen . . .
(third party in discussion with a B-Spot client)
Vera was not just a consultant but a member of the Inspire team. Her expertise helped us to develop our financial model, particularly the market size, where Vera’s skill at breaking down the epidemiology of our inherited diseases by genetic mutation created a tool which we use repeatedly in the gene therapy space.
Sandra (Sam) Donaldson, CEO
I had the pleasure of working closely with Vera on a recent project involving the development of a business modelling tool for our company in the vision care industry. I am compelled to share my utmost appreciation for her exceptional skills and contributions. Vera demonstrated an unparalleled attention to detail throughout the entire process. Her meticulous approach to the intricacies of business modeling was truly commendable. From the initial conceptualization to the final implementation, she ensured that every facet of the tool was thoroughly examined and optimized for precision. One of Vera's standout qualities is her profound knowledge of the pharmaceutical industry. She exhibited a deep understanding of the industry landscape, keeping abreast of the latest trends, and could even infer market dynamics. This industry insight greatly enhanced the relevance and effectiveness of the business modeling tool she crafted. I was particularly impressed by Vera's ability to dig into financial filings with precision and finesse. Her analytical skills were invaluable in extracting relevant data and translating it into actionable insights. This capability not only streamlined our decision-making process but also fortified the tool's foundation with robust financial underpinnings. Moreover, Vera showcased a remarkable talent for envisioning our company's place in the supply chain. Her strategic foresight and forward-thinking approach were pivotal in aligning the business modeling tool with our long-term objectives. This foresight has undoubtedly positioned our company for success in an ever-evolving industry landscape. In conclusion, I highly recommend Vera for her outstanding proficiency in business modeling, her in-depth knowledge of the pharmaceutical sector, and her ability to delve into financial intricacies. It was a pleasure collaborating with someone so dedicated and capable, and I am confident that her contributions will have a lasting positive impact on our business.
Gabrielle Masone, CEO
Vera has been critical and important asset to the development of our financial planning, go to market strategy and growth planning. She is viewed as an extension of our team and dives in headfirst into the company, the specifics around the market and learns everything quickly, efficiently and effectively. She can communicate complex financial and market analysis in a way that any founder, executive team, or investor could understand and is an absolute skill and talent on modelling. Her extensive knowledge and experience specifically in the Medtech industry made the onboarding, development, and execution of tasks seamless and easy. Vera is extremely knowledgeable, can take on any challenge and work around any timelines you give her to execute top quality work.
Rachel Bartholomew, CEO & Founder
Vera’s deep knowledge of the health sciences and investment space was a huge boon to Mesosil as we worked together to build a complex financial model and dynamic cap table that fit our unique business needs. The model has served as a fantastic basis for customization and has let us build complex internal budgets and forecasts, while letting those conducting due-diligence see a simple-to-understand overview of our business. We have received multiple comments from partners praising our financial organization and preparedness, which was directly enabled by Vera’s excellent work.
Cameron Steward, CEO
“I highly recommend Vera for her exceptional work in developing a comprehensive financial model for our med-tech startup. Her expertise in financial planning has been instrumental in shaping our company's timeline, budget, and product planning strategies. The model provided by Vera is not only robust and adaptable but also intuitive to use, making it an invaluable asset for our ongoing and future business decisions. Her ability to understand and incorporate our unique industry requirements into the model has significantly enhanced our strategic planning capabilities. We are deeply appreciative of her professionalism, attention to detail, and commitment to delivering results that exceed expectations.”
Dr. Saumik Biswas, CEO
Vera worked closely as a strategic advisor with our executive team to help FluidAI build a robust financial model demonstrating the company’s roadmap and future potential. Vera's shrewdness and domain expertise in financial modelling along with her strong understanding of how life sciences startups develop, scale, and commercialize allowed us to not only have a financial forecasting model, but also a powerful tool that helps explain FluidAI's path towards growth and profitability. That model will not only serve to tell our story to external stakeholders, but also act as our internal guide to support decision-making within the organization.
Amr Abdelgawad, COO
“B-Spot Consulting was an efficient and effective partner in the development of a sophisticated financial model for JVPLabs. The depth of analysis and attention to detail was second to none! Highly recommended.”
Dr. Andrew Smith MD CCFP(EM), MEng, CSO, Co-Founder
Vera has a broad and deep understanding of the range of processes necessary in biotech drug development ranging from preclinical design and management through commercialization targets AND analysis of prospective drug candidates. Her background in investment banking adds to her skill sets in corporate acquisitions. As Principal at B-Spot her advice regarding regulatory pathways and requirements, development risk mitigation and business plans is sound, rapidly produced, and at equitable cost.
David G.P. Allan
Principal, Cresswell Advisors Inc.
formerly Chairman & CEO YM BioSciences.
I personally have worked alongside Vera on multiple projects with great success. She has an innate ability to build business specific models that are detailed, allow scenario analysis and stand the test of VC diligence. It is great to have models that reflect your business today and can be easily changed to grow with your business. I have recommended B-Spot Consulting to many other C-level entrepreneurs, and all have thanked me.
Rocky Ganske
CEO, CellAegis Devices
Vera Belaoussoff, Msc, Principal
B-SPOT CONSULTING INC.
HERSTORY
The guidance counsellor in high school wouldn’t have been able to tell me what an Analyst was, and so I guess it wasn’t surprising that I didn’t know either.
“What’s an analyst?” I asked my next door neighbour, an investment banker at (then) Solomon-Smith Barney, as we were sitting on my porch sipping lemon martinis and handing out candies to kids at Hallowe’en. It was a balmy night. At the time I had been doing basic research in the Pharmacology Department at U of T in the area of schizophrenia, but basic research is a LONG way away from medical treatment. And I wanted to DO something more goal-oriented, with shorter timelines.
That was the impetus for my career move from academic research to finance. I started as sell-side analyst on Bay Street for a boutique investment dealer where I covered small-cap Canadian biotech companies, and from there I went to the buy-side at Scotia Cassels Investment Counsel to cover North American Equities (Healthcare). It was exciting. It was definitely a faster pace! Gone was the sleepy pace of lab work, replaced with a deluge of conference calls and deep-dives into data from conferences. I covered the Pharma companies, Biotechs, PBMs, HMOs, Med Devices, CROS, Drug Distributors, the Labs, all of it. I did try to pawn the HMOs off to our banking analyst: “They’re INSURANCE companies” I would say, to which he would respond, “They’re HEALTHCARE companies.” I never won that argument.
And it was great-- the scientific breadth I ended up covering satisfied my curious half, and the financial analysis satisfied my analytical half. But after a few years, I missed the depth, the deep deep dive into individual companies, getting to know the founders and entrepreneurs, and the solutions they were trying to bring to market. So eventually I left the banking sector, and I’ve never been more engaged than I am now, when I am working with entrepreneurial healthcare companies.
It’s always a pleasure to meet new people, so feel free to drop me a line and let me know about YOUR story. I’d love to hear it.